Literature DB >> 15153420

Multitasking in tumor progression: signaling functions of cell adhesion molecules.

Ugo Cavallaro1, Gerhard Christofori.   

Abstract

Approximately 90% of all cancer deaths arise from metastasis formation. Hence, understanding the molecular mechanisms underlying tumor progression, local invasion, and the formation of tumor metastases represents one of the great challenges in exploratory cancer research. Recent experimental results indicate that changes in cell adhesion play a critical role in tumor progression. Cell adhesion molecules of varying classes and functions, including cadherins, cell adhesion molecules of the immunoglobulin family (Ig-CAMs), CD44, and integrins, can interact with and modulate the signaling function of receptor tyrosine kinases (RTKs). Conversely, signaling by RTKs can directly affect the adhesive function of adhesion molecules. Loss of E-cadherin and gain of mesenchymal cadherin function as well as changes in the expression of Ig-CAMs during the progression of many cancer types exemplify such functional implicatons: cell adhesion molecules not only define a tumor cell's adhesive repertoire, but also directly influence classic signal transduction pathways, thereby modulating the metastatic behavior of tumor cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15153420     DOI: 10.1196/annals.1294.006

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  47 in total

1.  Analysis of metastasis suppressing function of E-cadherin in gastric cancer cells by RNAi.

Authors:  Zhi-Hong Zheng; Xiu-Ju Sun; Hai-Tao Zhou; Chao Shang; Hong Ji; Kai-Lai Sun
Journal:  World J Gastroenterol       Date:  2005-04-07       Impact factor: 5.742

Review 2.  Crossroads of integrins and cadherins in epithelia and stroma remodeling.

Authors:  Carolina Epifano; Mirna Perez-Moreno
Journal:  Cell Adh Migr       Date:  2012-05-01       Impact factor: 3.405

3.  Neural cell adhesion molecule isoform 140 declines with rise of WHO grade in human gliomas and serves as indicator for the invasion zone of multiform glioblastomas and brain metastases.

Authors:  Pedro Duenisch; Rupert Reichart; Ulrike Mueller; Michael Brodhun; Rolf Bjerkvig; Bernd Romeike; Jan Walter; Christian Herbold; Christian R A Regenbrecht; Rolf Kalff; Susanne A Kuhn
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-04       Impact factor: 4.553

4.  Cadherin-11, a marker of the mesenchymal phenotype, regulates glioblastoma cell migration and survival in vivo.

Authors:  Harpreet Kaur; Polly J Phillips-Mason; Susan M Burden-Gulley; Amber E Kerstetter-Fogle; James P Basilion; Andrew E Sloan; Susann M Brady-Kalnay
Journal:  Mol Cancer Res       Date:  2012-01-20       Impact factor: 5.852

5.  Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases.

Authors:  Aaron P Putzke; Aviva P Ventura; Alexander M Bailey; Canan Akture; John Opoku-Ansah; Müge Celiktaş; Michael S Hwang; Douglas S Darling; Ilsa M Coleman; Peter S Nelson; Holly M Nguyen; Eva Corey; Muneesh Tewari; Colm Morrissey; Robert L Vessella; Beatrice S Knudsen
Journal:  Am J Pathol       Date:  2011-05-04       Impact factor: 4.307

6.  TGFBI expression reduces in vitro and in vivo metastatic potential of lung and breast tumor cells.

Authors:  Gengyun Wen; Michael A Partridge; Bingyan Li; Mei Hong; Wupeng Liao; Simon K Cheng; Yongliang Zhao; Gloria M Calaf; Tian Liu; Jun Zhou; Zengli Zhang; Tom K Hei
Journal:  Cancer Lett       Date:  2011-05-10       Impact factor: 8.679

7.  Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death.

Authors:  Ana P Castano; Tatiana N Demidova; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2005-03       Impact factor: 3.631

8.  The expression of VE-cadherin in breast cancer cells modulates cell dynamics as a function of tumor differentiation and promotes tumor-endothelial cell interactions.

Authors:  Maryam Rezaei; Jiahui Cao; Katrin Friedrich; Björn Kemper; Oliver Brendel; Marianne Grosser; Manuela Adrian; Gustavo Baretton; Georg Breier; Hans-Joachim Schnittler
Journal:  Histochem Cell Biol       Date:  2017-11-15       Impact factor: 4.304

Review 9.  EGF receptor-targeted nanocarriers for enhanced cancer treatment.

Authors:  Alyssa M Master; Anirban Sen Gupta
Journal:  Nanomedicine (Lond)       Date:  2012-12       Impact factor: 5.307

Review 10.  DNA and histone methylation in gastric carcinogenesis.

Authors:  Danielle Queiroz Calcagno; Carolina Oliveira Gigek; Elizabeth Suchi Chen; Rommel Rodriguez Burbano; Marília de Arruda Cardoso Smith
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.